2008 - Fellow of the American Association for the Advancement of Science (AAAS)
His primary areas of study are Cancer research, Molecular biology, Pathology, Stem cell and Hepatocellular carcinoma. He has researched Cancer research in several fields, including Carcinogenesis, Cancer, Immunology and Gene expression profiling. The study incorporates disciplines such as Regulation of gene expression and Gene silencing in addition to Carcinogenesis.
His Molecular biology research includes themes of Cell culture, In vitro, Gene expression and Transforming growth factor, Transforming growth factor beta. Snorri S. Thorgeirsson interconnects Embryonic stem cell, Cellular differentiation and Liver regeneration in the investigation of issues within Stem cell. In Hepatocellular carcinoma, Snorri S. Thorgeirsson works on issues like Carcinoma, which are connected to Oncology.
Snorri S. Thorgeirsson focuses on Cancer research, Molecular biology, Biochemistry, Internal medicine and Carcinogenesis. His Cancer research study combines topics in areas such as Cancer and Stem cell. His Stem cell research is multidisciplinary, incorporating elements of Cellular differentiation and Pathology.
His Molecular biology study combines topics from a wide range of disciplines, such as Cell culture, Gene expression, Cell growth, Hepatocyte and Liver regeneration. The various areas that Snorri S. Thorgeirsson examines in his Internal medicine study include Endocrinology and Oncology. His work is dedicated to discovering how Carcinogenesis, Genetically modified mouse are connected with Transforming growth factor and other disciplines.
Cancer research, Liver cancer, Hepatocellular carcinoma, Cancer and Internal medicine are his primary areas of study. His Cancer research research includes elements of Cancer cell, Cancer stem cell, Stem cell, Carcinogenesis and Pathology. His study on Stem cell also encompasses disciplines like
His study in Pathology is interdisciplinary in nature, drawing from both Progenitor cell and Extracellular matrix. His research in Hepatocellular carcinoma focuses on subjects like Immunohistochemistry, which are connected to Western blot. His studies in Internal medicine integrate themes in fields like Endocrinology and Oncology.
Snorri S. Thorgeirsson mainly focuses on Cancer research, Liver cancer, Stem cell, Hepatocellular carcinoma and Cancer. His study in Cancer research is interdisciplinary in nature, drawing from both Progenitor cell, Cancer stem cell, Side population, Cancer cell and Molecular biology. His research ties Small hairpin RNA and Molecular biology together.
Snorri S. Thorgeirsson has included themes like Malignant transformation, Immunology, Etiology and Genomics in his Liver cancer study. Pathology, Hepatocyte growth factor, Hepatic stellate cell, In vivo and Induced pluripotent stem cell is closely connected to Cellular differentiation in his research, which is encompassed under the umbrella topic of Stem cell. Hepatocellular carcinoma is the subject of his research, which falls under Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Molecular pathogenesis of human hepatocellular carcinoma
Snorri S. Thorgeirsson;Joe W. Grisham;Joe W. Grisham.
Nature Genetics (2002)
Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen.
D.J. Jollow;S.S. Thorgeirsson;W.Z. Potter;M. Hashimoto.
Pharmacology (1974)
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.
Ju-Seog Lee;Jeonghoon Heo;Louis Libbrecht;In-Sun Chu.
Nature Medicine (2006)
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
Ju-Seog Lee;In-Sun Chu;Jeonghoon Heo;Diego Francesco Calvisi.
Hepatology (2004)
Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair
Chang-Goo Huh;Valentina M. Factor;Aránzazu Sánchez;Koichi Uchida.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.
Nancy Sanderson;Valentina Factor;Peter Nagy;Jeffrey Kopp.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.
Cédric Coulouarn;Valentina M. Factor;Jesper B. Andersen;Marian E. Durkin.
Oncogene (2009)
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Diego F. Calvisi;Sara Ladu;Alexis Gorden;Miriam Farina.
Gastroenterology (2006)
A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.
Stephanie Roessler;Hu Liang Jia;Anuradha Budhu;Marshonna Forgues.
Cancer Research (2010)
Adenovirus-mediated in vivo gene transfer and expression in normal rat liver.
Jaffe Ha;Danel C;Longenecker G;Metzger M.
Nature Genetics (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
Mayo Clinic
National Institutes of Health
Johannes Gutenberg University of Mainz
KU Leuven
National Institutes of Health
National Institutes of Health
Imperial College London
Fudan University
National Institutes of Health
University of Vienna
Columbia University
National Research Council (CNR)
University of California, Davis
University of Toronto
University of Siena
Kindai University
University of Amsterdam
University of Helsinki
JMI Laboratories
Utrecht University
British Geological Survey
University of Colorado Boulder
University of Giessen
Yale University
Ludwig-Maximilians-Universität München